Trial intelligence / Profile preview

PROMET II: Phenotype Analysis in CRPC

NCT02282644Completed

Sponsor
Hospices Civils de Lyon
Start
Sep 2014
Primary completion
Aug 2017
Countries
1
01

Overview

Single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Risk of death according to positive markers at 2 years. Started Sep 2014; status: completed.

Beyond the preview

Go deeper on NCT02282644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02282644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call